ArticleExperimental & applied acarology2026
Snapback high resolution melting analysis for the rapid detection and differentiation of the L925 mutations associated with resistance to synthetic pyrethroids in Varroa destructor.
Article in Experimental & applied acarology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The honey bee parasite Varroa destructor is the major cause of colony loss in many countries, including New Zealand. Reports of less successful treatment schedules with synthetic pyrethroids are raising concerns of treatment failure due to genetic resistance to the pyrethroids arising in the mites. Here we describe an inexpensive, single-tube, and rapid detection method to both detect and differentiate the three knockdown resistance (kdr) mutations that are the major cause of pyrethroid resistance in Varroa globally. This method - employing two unlabelled qPCR primers - avoids the expense of individual mutation-specific probes. Its lower cost and rapid implementation mean new mutation assays can be easily developed for Varroa and other treatment resistance analyses. The use of this test over the last eight years has not detected the presence of the L925 kdr mutations in Varroa assessed in New Zealand to date.
Indexed as
Identifiers
41824098What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.